Science Explorer Back to mapMap

Most cited papers in Synthesis and biological activity

What are the most cited papers in Synthesis and biological activity?

The most cited paper in Synthesis and biological activity is "Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases" (Gary L. Johnson, Razvan Lapadat, 2002), with 4,334 citations. Next come "Multicomponent Reactions with Isocyanides" (4,073) and "A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases" (3,107).

Showing 50 of 100 papers. Every paper with more than 626 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases Gary L. Johnson, Razvan Lapadat · Science 5 Dec 2002 4,334
2 Multicomponent Reactions with Isocyanides Alexander S. S. Dömling, Ivar Ugi · Angewandte Chemie International Edition 15 Sep 2000 4,073
3 A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases Arup K. Ghose, Vellarkad N. Viswanadhan, John J. Wendoloski · Journal of Combinatorial Chemistry 18 Dec 1998 3,107
4 Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase Margaret F. Favata, Kurumi Y. Horiuchi, Elizabeth J. Manos et al. · Journal of Biological Chemistry Open access Jul 1998 3,045
5 Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Patrick J. Roberts, Channing J. Der · Oncogene 14 May 2007 2,821
6 The Properties of Known Drugs. 1. Molecular Frameworks Guy W. Bemis, Mark A. Murcko · Journal of Medicinal Chemistry 1996 2,604
7 Molecular Docking and Structure-Based Drug Design Strategies Leonardo L. G. Ferreira, Ricardo Nascimento dos Santos, Glaucius Oliva et al. · Molecules Open access 22 Jul 2015 2,578
8 Molecular Docking: Shifting Paradigms in Drug Discovery Luca Pinzi, Giulio Rastelli · International Journal of Molecular Sciences Open access 4 Sep 2019 2,376
9 Flavonoids: antioxidants or signalling molecules? Robert J. Williams, Jeremy P.E. Spencer, Catherine A Rice-Evans · Free Radical Biology and Medicine 2 Feb 2004 2,021
10 Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis Yu Sun, Wenzhou Liu, Tao Liu et al. · Journal of Receptors and Signal Transduction 22 Jun 2015 1,922
11 Ligand efficiency: a useful metric for lead selection Andrew L. Hopkins, Colin R. Groom, Alexander Alex · Drug Discovery Today 23 Apr 2004 1,857
12 THE FUNCTION OF CYTIDINE COENZYMES IN THE BIOSYNTHESIS OF PHOSPHOLIPIDES Eugene Paul Kennedy, Samuel B. Weiss · Journal of Biological Chemistry Open access Sep 1956 1,848
13 Advances in Copper Complexes as Anticancer Agents Carlo Santini, Maura Pellei, Valentina Gandin et al. · Chemical Reviews Review 8 Oct 2013 1,786
14 A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications Nagaraju Kerru, Lalitha Gummidi, Suresh Maddila et al. · Molecules Open access 20 Apr 2020 1,719
15 Role of Quinones in Toxicology Judy L. Bolton, Michael A. Trush, T.M. Penning et al. · Chemical Research in Toxicology 23 Feb 2000 1,707
16 A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Yuesheng Zhang, Paul Talalay, C G Cho et al. · Proceedings of the National Academy of Sciences Open access 15 Mar 1992 1,689
17 Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 Lars Ruddigkeit, Ruud van Deursen, Lorenz C. Blum et al. · Journal of Chemical Information and Modeling Open access 22 Oct 2012 1,584
18 Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen Michael R. Boyd, Kenneth D. Paull · Drug Development Research Feb 1995 1,565
19 Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase Richard J. Kitz, Irwin B. Wilson · Journal of Biological Chemistry Open access Oct 1962 1,525
20 Chalcone: A Privileged Structure in Medicinal Chemistry Chunlin Zhuang, Wen Zhang, Chunquan Sheng et al. · Chemical Reviews ReviewOpen access 10 May 2017 1,465
21 Pharmacology of oleanolic acid and ursolic acid Jie Liu · Journal of Ethnopharmacology Dec 1995 1,432
22 Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial David Planchard, Egbert Frederik Smit, Harry J.M. Groen et al. · The Lancet Oncology Open access 11 Sep 2017 1,387
23 Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity James Y. Tsai et al. · Proceedings of the National Academy of Sciences Open access 19 Feb 2008 1,368
24 Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource Dmitry A. Filimonov, Alexey A. Lagunin, Tatyana A. Gloriozova et al. · Chemistry of Heterocyclic Compounds 27 May 2014 1,347
25 Benchmarking Sets for Molecular Docking Niu Huang, Brian K. Shoichet, John J. Irwin · Journal of Medicinal Chemistry Open access 26 Oct 2006 1,342
26 Multicomponent reactions: advanced tools for sustainable organic synthesis Răzvan C. Cioc, Eelco Ruijter, Romano V. A. Orrù · Green Chemistry 2014 1,332
27 Biologically active dihydropyrimidones of the Biginelli-type — a literature survey Christian Oliver Kappe · European Journal of Medicinal Chemistry Dec 2000 1,332
28 H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. Markus Meyer, Ralf Schreck, Patrick A. Baeuerle · The EMBO Journal Open access May 1993 1,322
29 Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes Cláudio Viegas, Eliezer J. Barreiro, Carlos Alberto Manssour Fraga · Current Medicinal Chemistry 30 Jun 2007 1,310
30 100 years of the biginelli dihydropyrimidine synthesis Christian Oliver Kappe · Tetrahedron Aug 1993 1,226
31 Biological Activities of Hydrazone Derivatives Sevım Rollas, Şükriye Güniz Küçükgüzel · Molecules Open access 17 Aug 2007 1,221
32 p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Sanjay Kumar, Jeffrey C. Boehm, John C. Lee · Nature Reviews Drug Discovery Review Sep 2003 1,211
33 Schiff bases: A short review of their antimicrobial activities Cleiton Moreira da Silva, Daniel L. da Silva, Luzia Valentina Modolo et al. · Journal of Advanced Research Open access 11 Jun 2010 1,197
34 Fluorine in medicinal chemistry: A review of anti-cancer agents Chukwuemeka Isanbor, David O’Hagan · Journal of Fluorine Chemistry 24 Feb 2006 1,121
35 Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog Christian Oliver Kappe · Accounts of Chemical Research 28 Sep 2000 1,101
36 A review of anti-infective and anti-inflammatory chalcones Zdzisława Nowakowska · European Journal of Medicinal Chemistry Open access 16 Nov 2006 1,083
37 Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK Audrey Minden, Anning Lin, Martin McMahon et al. · Science 9 Dec 1994 1,083
38 Extended Functional Groups (EFG): An Efficient Set for Chemical Characterization and Structure-Activity Relationship Studies of Chemical Compounds E.S. Salmina, Norbert Haider, Igor V. Tetko · Molecules Open access 23 Dec 2015 1,045
39 “Multi-component Reactions : Emerging Chemistry in Drug Discovery” ‘From Xylocain to Crixivan’ Christopher Hulme, Vijay Gore · Current Medicinal Chemistry 2003 1,035
40 Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review Khalid Karrouchi, Smaail Radi, Youssef Ramli et al. · Molecules Open access 12 Jan 2018 1,008
41 Small Heterocycles in Multicomponent Reactions Benjamin H. Rotstein, Serge Zaretsky, Vishal Rai et al. · Chemical Reviews Review 17 Jul 2014 1,008
42 Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities Konstantina C. Fylaktakidou, Dimitra Hadjipavlou‐Litina, Κonstantinos E. Litinas et al. · Current Pharmaceutical Design Nov 2004 974
43 970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13 Lorenz C. Blum, Jean‐Louis Reymond · Journal of the American Chemical Society 8 Jun 2009 928
44 New Method for Fast and Accurate Binding‐site Identification and Analysis Tom Halgren · Chemical Biology & Drug Design Feb 2007 924
45 Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial David Planchard, Benjamin Besse, Harry J.M. Groen et al. · The Lancet Oncology Open access 6 Jun 2016 897
46 A review on recent developments of indole-containing antiviral agents Ming‐Zhi Zhang, Qiong Chen, Guang‐Fu Yang · European Journal of Medicinal Chemistry Open access 23 Oct 2014 888
47 Apoptosis induced by anticancer drugs John A. Hickman · Cancer and Metastasis Reviews Review Sep 1992 878
48 Medicinal attributes of 1,2,3-triazoles: Current developments Divya Dheer, Virender Singh, Ravi A. Shankar · Bioorganic Chemistry 18 Jan 2017 877
49 Drugs, their targets and the nature and number of drug targets Peter Imming, Christian Sinning, Achim Meyer · Nature Reviews Drug Discovery Review Oct 2006 857
50 Antibacterial Activities of Flavonoids: Structure-Activity Relationship and Mechanism Yixi Xie, Weijie Yang, Fen Tang et al. · Current Medicinal Chemistry 27 Sep 2014 855

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.